Zimmer, L., Utikal, J., & Enk, A. (2015). Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma. PLOS ONE, 10(3), . https://doi.org/10.1371/journal.pone.0118564
Chicago Style (17th ed.) CitationZimmer, Lisa, Jochen Utikal, and Alexander Enk. "Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma." PLOS ONE 10, no. 3 (2015). https://doi.org/10.1371/journal.pone.0118564.
MLA (9th ed.) CitationZimmer, Lisa, et al. "Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma." PLOS ONE, vol. 10, no. 3, 2015, https://doi.org/10.1371/journal.pone.0118564.
Warning: These citations may not always be 100% accurate.